Acumen Pharmaceuticals, Inc. Common Stock (NASDAQ: ABOS) last traded at $1.82, down 10.15% on the session. The quote above updates while this page is open; the figures below are drawn from Acumen Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Acumen Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker ABOS. Its market capitalisation is $131.26 million.
Valuation measures for Acumen Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $131.26M |
|---|---|
| Enterprise value | $130.56M |
| Price / book | 2.29 |
| Beta | 2.01 |
Trailing-twelve-month figures tagged in Acumen Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$105.04M |
| EPS (TTM) | -$1.62 |
|---|
| Return on equity | -183.44% |
|---|
| Cash | $59.44M |
|---|
Range and volume for ABOS over the past 52 weeks.
| 52-week high | $3.60 |
|---|---|
| 52-week low | $1.50 |
| Volume | 646.0K |
| Average volume | 441.1K |
| Previous close | $2.02 |
Invest a chosen dollar amount in Acumen Pharmaceuticals, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ABOS.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.